홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

1,2,3,4,6,7,9-헵타클로로디벤조-P-다이옥신

1,2,3,4,6,7,9-Heptachlorodibenzo-P-dioxin

HCID 42672
노트반응
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
58200-70-7
표준 SMILES
Clc1cc(Cl)c2c(c1Cl)Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1O2
InChIKey
KTJJIBIRZGQFQZ-UHFFFAOYSA-N
분자식
C12HCl7O2
평균 분자량
425.3 g/mol
단동위원소 질량
421.779623

개요

1,2,3,4,6,7,9-heptachlorodibenzo-p-dioxin is a white solid. Insoluble in water. (NTP, 1992)

이름 및 식별자

우선 이름
1,2,3,4,6,7,9-Heptachlorodibenzo-P-dioxin
IUPAC
1,2,3,4,6,7,9-heptachlorodibenzo-p-dioxin
현지명
1,2,3,4,6,7,9-헵타클로로디벤조-P-다이옥신
영어명
1,2,3,4,6,7,9-Heptachlorodibenzo-p-dioxin
분자식
C12HCl7O2
분자량
425.31

이름 및 동의어

1,2,3,4,6,7,9-HEPTACHLORODIBENZO-P-DIOXIN58200-70-71,2,3,4,6,7,9-HeptachlorodibenzodioxinDibenzo-p-dioxin, 1,2,3,4,6,7,9-heptachloro-BRN 1630270UNII-D157DW362AD157DW362ADibenzo(b,e)(1,4)dioxin, 1,2,3,4,6,7,9-heptachloro-1,2,3,4,6,7,9-Heptachlorodibenzo-para-dioxinPCDD 741,2,3,4,6,7,9-HpCDD1,2,3,4,6,7,9-HEPTACHLORODIBENZO[1,4]DIOXIN
이름 더 보기
1,2,3,4,6,7,9-헵타클로로디벤조-P-다이옥신1,2,3,4,6,7,9-CDDHEPTACHLORODIBENZO-PARA-DIOXINS1,2,3,4,6,7,9-heptachloro-dibenzo-p-dioxi1,2,3,4,6,8,9-Heptachlorodibenzo-p-dioxinDibenzo[b,e][1,4]dioxin, 1,2,3,4,6,7,9-heptachloro-
1,2,3,4,6,7,9-HEPTACHLORODIBENZO(1,4)DIOXINRefChem:712611,2,3,4,6,7,9-HCDD1,2,3,4,6,7,9-HEPTACHLORODIBENZO(B,E)(1,4)DIOXIN5-19-02-00042 (Beilstein Handbook Reference)1,2,3,4,6,7,9-HEPTACHLOROOXANTHRENESCHEMBL8858507DTXSID40973764

데이터베이스 식별자

물성

구조 계산 물성

XLogP
7.5
극성 표면적
18.5 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
2
회전 가능 결합 수
0
무거운 원자 수
21
형식 전하
0
복잡도
400

실험 및 물리화학적 성질

SolubilityInsoluble (NTP, 1992)
Physical Description1,2,3,4,6,7,9-heptachlorodibenzo-p-dioxin is a white solid. Insoluble in water. (NTP, 1992)

물리화학적 성질

녹는점
265 °C · 265°C (estimate)
끓는 점
506.1 °C · 506.1°C (rough estimate)
밀도
1.886 · 1.8860 (estimate)
굴절률
1.671 · 1.6710 (estimate)
Henry's Law Constant
3.4 · 3.4×100 mol/(m3Pa) at 25℃, Wang and Wong (2002)
EPA
1 · 1,2,3,4,6,7,9-Heptachlorodibenzo-p-dioxin (58200-70-7)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

유해성 정보

DOT LabelPoison
Fire HazardsFlash point data for this chemical are not available. It is probably combustible. (NTP, 1992)
Health HazardsSYMPTOMS: Symptoms of exposure to this compound may include eye irritation, chloracne and liver damage.
Reactive GroupEthers
Reactivity Profile1,2,3,4,6,7,9-HEPTACHLORODIBENZO-P-DIOXIN may be sensitive to prolonged exposure to light. (NTP, 1992)
Air and Water ReactionsInsoluble in water.

안전 및 보호

Fire FightingFires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1건

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1건

SMALL SPILLS AND LEAKAGE: If you spill this chemical, FIRST REMOVE ALL SOURCES OF IGNITION, then dampen the solid spill material with toluene, then transfer the dampened material to a suitable container. Use absorbent paper dampened with toluene to pick up any remaining material. Your contaminated clothing and absorbent paper should be sealed in a vapor-tight plastic bag for eventual disposal. Solvent-wash all contaminated surfaces with toluene followed by washing with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

화학 및 산업

약리 정보

Metabolism/Metabolites · 1건

CDDs are absorbed through oral, inhalation, and dermal routes of exposure. CDDs are carried in the plasma by serum lipids and lipoproteins, distributing mainly to the liver and adipose tissue. CDDs are very slowly metabolized by the microsomal monooxygenase system to polar metabolites that can undergo conjugation with glucuronic acid and glutathione. They may increase the rate of their own metabolism by inducing both phase I and phase II enzymes. The major routes of excretion of CDDs are the bile and the faeces, though smaller amounts are excreted in the urine and via lactation. (L177)

용도 및 제조

Uses · 1건

Dioxins occur as by-products from the manufacture of organochlorides, the bleaching of paper, chlorination by waste and drinking water treatment plants, municipal solid waste and industrial incinerators, and natural sources such as volcanoes and forest fires. (L177, L178)

응용 분야

일반 설명White solid. Insoluble in water.

공급사5 곳

上海稳同科技有限公司02151600108 13062666369 · [email protected]
天津阿尔塔科技有限公司022-6537-8550 15522853686 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
青岛腾龙微波科技有限公司0532-83818797 17669478191 · [email protected]
北京百灵威科技有限公司18210857532 18210857532 · [email protected]

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
CAS
58200-70-7
PubChem CID
42672
DTXSID
DTXSID40973764
UNII
D157DW362A
Nikkaji
J74.771H
Isolation and EvacuationExcerpt from ERG Guide 154 [Substances - Toxic and/or Corrosive (Non-Combustible)]:
Minimum Risk LevelAcute Oral: 0.0002 ug/kg/day (L134) Intermediate Oral: 0.00002 ug/kg/day (L134) Chronic Oral: 0.000001 ug/kg/day (L134)
Personal Protective Equipment (PPE)MINIMUM PROTECTIVE CLOTHING: If Tyvek-type disposable protective clothing is not worn during handling of this chemical, wear disposable Tyvek-type sleeves taped to your gloves.

독성 정보

TreatmentTreatment of CDD exposure may include washing the area of contact, GI decontamination, administering an IV, or forced alkaline diuresis. (L346)
Health Effects · 1건

Exposure to large amounts of CDDs causes chloracne, a severe skin disease with acne-like lesions that occur mainly on the face and upper body. CDDs may also cause liver damage and induce long-term alterations in glucose metabolism and subtle changes in hormonal levels. In addition, studies have shown that CDDs may disrupt the endocrine system and weaken the immune system, as well as cause reproductive damage and birth defects, central and peripheral nervous system pathology, thyroid disorders, endometriosis, and diabetes. (L177, L178)

Exposure RoutesOral (L177) ; inhalation(L177) ; dermal (L177)
Toxicity Summary · 1건

CDDs cause their toxic effects by binding to the aryl hydrocarbon receptor and subsequently altering the transcription of certain genes. The affinity for the Ah receptor depends on the structure of the specific CDD. The change in gene expression may result from the direct interaction of the Ah receptor and its heterodimer-forming partner, the aryl hydrocarbon receptor nuclear translocator, with gene regulatory elements or the initiation of a phosphorylation/dephosphorylation cascade that subsequently activates other transcription factors. The affected genes include several oncogenes, growth factors, receptors, hormones, and drug-metabolizing enzymes. The change in transcription/translation of these genes is believed to be the cause of most of the toxic effects of CDDs. (L177)

Signs and SymptomsIn addition to chloracne, CDD exposure causes skin rashes, discoloration, and excessive body hair. (L177)
Carcinogen Classification3, not classifiable as to its carcinogenicity to humans. (L135)